Skip to main content
. 2020 Apr 7;8(4):80. doi: 10.3390/biomedicines8040080
HCV Hepatitis C virus
CHC Chronic hepatitis C
HCC Hepatocellular carcinoma
DAAs Direct-acting antivirals
RAS Resistance-associated substitution